Seven New CSL Global Research Acceleration Initiative Awardees Announced to Fast-Track Therapeutics Innovation
Initiative Freshly Inks Promising Research Partnerships in Europe and, for the first time, Asia and the UK
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and Products
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and Products
CSL Behring. Leading the Way in Treating Rare and Serious Diseases.
CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.
More About CSL Behring
CSL Plasma. Helping Those in Need Live Healthier Lives.
CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with more than 300 plasma collection centers in the U.S., Europe and China. The plasma collected is used by CSL Behring for the purpose of manufacturing and delivering its life-saving therapies to people in more than 100 countries.
More About CSL Plasma
CSL Seqirus. On the Front Line of Public Health Protection.
As the only vaccine company with a singular global focus on influenza, we work tirelessly on cutting-edge research, transformative technologies, and the latest methods of production and distribution. Together with our partners we’re on the front line every day, working to help protect communities from seasonal influenza and global pandemic threats.
More About CSL Seqirus
CSL Vifor. Changing the Game in Iron Deficiency and Nephrology.
The newest member of the CSL family, CSL Vifor is a global leader in iron deficiency and nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.
More About CSL ViforVita: Original Stories
'Vita' means life. It's also where we share the stories of biotech's promise to patients and public health.
Video: Getting to Know CSL Vifor
Watch a video that introduces CSL Vifor’s role as the “home of iron” at its manufacturing site in St. Gallen, Switzerland.
CSL's Chief Sustainability Officer on Climate Week 2023
Expanding deep collaboration across industries will help make meaningful advancement on our shared goals.
New Book on Emil von Behring
Just in time for Nobel Prize week, a historian in Marburg, Germany, has authored a biography of von Behring.
Careers at CSL
We are committed to helping employees fulfill their career aspirations while working in a values-based culture. Are you next?
Congratulations to the newest CSL Global Research Acceleration Initiative partnership awardees. Seven medical researchers have been awarded a CSL Research Acceleration Initiative \(RAI\) partnership, including up to a AU$500,000 investment in each program over two years, to fast-track the discovery of innovative biotherapies to address unmet medical needs. The CSL Research Acceleration Initiative establishes partnerships between CSL and global research organisations to accelerate commercialisation of promising discovery programs. In addition to creating long-term mutual partnerships to further innovation, the initiative includes funding as well as access to CSL R&D experts. To learn more about the investigators and technologies selected in the 2022 program, click here https://bit.ly/46BNLzc
The Nobel Prize is more than an award – it's a testament to human perseverance and ingenuity. As we applaud this year’s laureates in chemistry, we at CSL are reminded of our mission: leveraging science for a healthier world. Let's celebrate the brilliance of chemistry and its transformative impact. #NobelPrizeWeek
Throughout September, CSL employees from around the world came together in an effort to ‘step up’ to prevent #HeartDisease through our ‘7 Million Steps’ challenge, representing the number of people worldwide who are impacted by #HeartAttacks each year. Congratulations to our winners and thank you to all participants for showcasing how everyone plays a role in helping CSL change the course of #CVD ! #WorldHeartDay
A historian with access to thousands of letters has published a new biography of Emil von Behring, namesake of CSL Behring and winner of the first-ever Nobel Prize in Medicine. It's #NobelPrize Week! https://bit.ly/3tntoaH
On National Child Health Day in the U.S., we salute the dedication of families and all those working tirelessly to ensure a brighter, healthier future for our children. Let's remember the profound impact of family income on a child's health, both physically and mentally, and come together to advocate for change. #NationalChildHealthDay
During Global Diversity Awareness Month, we celebrate the strength that lies in our differences. At CSL, we value diversity and strive to create an inclusive workplace that empowers every individual. #GlobalDiversityMonth #PromisingFutures #CSL
As we recognize Health Literacy Month, CSL remains dedicated to bridging the gap between complex medical information and our community's understanding. Let’s champion the cause and create a world where everyone can make informed health choices. #HealthLiteracyMonth
CSL Behring in Bern, Switzerland was delighted to host the Women Back to Business program from the Executive School – Universität St.Gallen (HSG) . This initiative supports women with technical degrees looking to re-enter the workforce, redefine their careers, or take on more responsibilities. CSL Behring has been proud to support the program since 2021, offering a tailored agenda that includes expert-led site tours, keynote participation, CV workshops, and networking opportunities. It was a great day for us to connect with talented female leaders, gain market insights, and share tips for their professional journeys. #CSL #DoWorkThatMatters #PromisingFutures
Hear Jeffrey Ball, CSL’s Chief Sustainability Officer, share his thoughts on Climate Week 2023!
Today on #WorldHeartDay , our VP of Global Commercial Development, CVM weighs in on how CSL is committed to #UseHeart today, to deliver on our promises for a healthier tomorrow.